History: Princeton West Innovation Campus
Former Exxon Mobil Research & Development Site of 1.2M SF and Additional Land
Bristol-Myers Squibb Purchased in 1995/1996
BMS Renovation: $42M
BMS made significant capital improvements to the entire site over its 25 years of ownership
Building 9/10 renovated in 2017 for clinical-phase manufacturing of monoclonal antibodies with single use technologies
Open Lab / Office
PTC Signed a 15-year Lease for 220,517 RSF in 2020
Conversion of Cell Line Development Labs to GMP Plasmid Manufacturing Suite
Installation of Vanrx MicroCell Filler
Conversion of Wing 4 Purification Suite from Grade D to Grade C
Renovation of QC Laboratory
Lincoln Equities Purchased the Entire Site from BMS in 2020
PTC Improvements: $30M
PTC Equipment: $30M
Additional life science tenants: Passage Bio, Gennao Bio, Enzene Biosciences, and Rocket Pharma (2020-2023)
Sold undeveloped land to BeiGene (2021)
400,000 SF new cancer treatment manufacturing facility under construction
Sold 200,000 SF vivarium facility to Princeton (2022)
Total Capital Improvements in 220,517 RSF Since 2017:
$102M
$462/RSF
Development and Manufacturing Improvements
